Relationship between serum cardiac troponin T level and cardiopulmonary function in stable chronic obstructive pulmonary disease

International Journal of COPD

Volumn 10, Issue , 2015, Pages 309-320

  Hattori, Kumiko ^a   Ishii, Takeo ^a   Motegi, Takashi ^a   Kusunoki, Yuji ^a   Gemma, Akihiko ^a   Kida, Kozui ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Aging; C reactive protein; Chronic obstructive pulmonary disease; Troponin T

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; TROPONIN T; AUTACOID; BIOLOGICAL MARKER; TNNT2 PROTEIN, HUMAN;

AGE; AGED; ARTERIAL OXYGEN TENSION; ARTICLE; CARDIOPULMONARY FUNCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEART RIGHT VENTRICLE OVERLOAD; HEART RIGHT VENTRICLE PRESSURE; HEART RIGHT VENTRICLE SYSTOLIC PRESSURE; HUMAN; LUNG DIFFUSION CAPACITY; MAJOR CLINICAL STUDY; MALE; SMOKING; BLOOD; COMPLICATION; ECHOCARDIOGRAPHY; EXERCISE TOLERANCE; HEART DISEASES; LUNG; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTOR; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SPIROMETRY; STATISTICAL MODEL; WALKING;

AGE FACTORS; AGED; BIOMARKERS; ECHOCARDIOGRAPHY; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HEART DISEASES; HUMANS; INFLAMMATION MEDIATORS; LINEAR MODELS; LUNG; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SPIROMETRY; TOMOGRAPHY, SPIRAL COMPUTED; TROPONIN T; WALKING;

EID: 84922746146     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S76293     Document Type: Article

References (30)

1. Patel AR, Hurst JR. Extrapulmonary comorbidities in chronic obstructive pulmonary disease: State of the art. Expert Rev Respir Med. 2011;5(5):647–662.
2. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet. 2012;379(9823):1341–1351.
3. Singh V, Martinezclark P, Pascual M, Shaw ES, O’Neill WW. Cardiac biomarkers – the old and the new: A review. Coron Artery Dis. 2010;21(4):244–256.
4. Røysland R, Kravdal G, Høiseth AD, et al. Cardiac troponin T levels and exercise stress testing in patients with suspected coronary artery disease: The Akershus Cardiac Examination (ACE) 1 study. Clin Sci (Lond). 2012;122(12):599–606.
5. Turer AT, Addo TA, Martin JL, et al. Myocardial ischemia induced by rapid atrial pacing causes troponin T release detectable by a high sensitive assay: Insights from a coronary sinus sampling study. J Am Coll Cardiol. 2011;57(24):2398–2405.
6. Hickman PE, Potter JM, Aroney C, et al. Cardiac troponin may be released by ischemia alone, without necrosis. Clin Chim Acta. 2010;411(5–6):318–323.
7. Brekke PH, Omland T, Holmedal SH, Smith P, Søyseth V., Troponin T. Elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation. Eur Respir J. 2008;31(3):563–570.
8. Høiseth AD, Neukamm A, Karlsson BD, Omland T, Brekke PH, Søyseth V. Elevated high-sensitivity cardiac troponin T is associated with increased mortality after acute exacerbation of chronic obstructive pulmonary disease. Thorax. 2011;66(9):775–781.
9. Høiseth AD, Omland T, Hagve TA, Brekke PH, Søyseth V. Determinants of high-sensitivity cardiac troponin T during acute exacerbation of chronic obstructive pulmonary disease: A prospective cohort study. BMC Pulm Med. 2012;12:22.
10. Søyseth V, Bhatnagar R, Holmedahl NH, et al. Acute exacerbation of COPD is associated with fourfold elevation of cardiac troponin T. Heart. 2013;99(2):122–126.
11. Neukamm AM, Høiseth AD, Hagve TA, Søyseth V, Omland T. High-sensitivity cardiac troponin T levels are increased in stable COPD. Heart. 2013;99(6):382–387.
12. Thurlbeck WM, Wright JL. Disease in the other organ. In: William Michael Thurlbeck, Joanne Lynne Wright, editors. Thurlbeck’s Chronic Airflow Obstruction. 2nd ed. London, UK: BC Decker Inc; 1999.
13. Bhatt SP, Dransfield MT. Chronic obstructive pulmonary disease and cardiovascular disease. Transl Res. 2013;162(4):237–251.
14. No authors listed. Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med. 1995;152(3):1107–1136.
15. Global Initiative for Chronic Obstructive Lung Disease. 2004 update: Workshop Report, Global Strategy for Diagnosis, Management and Prevention of COPD. Available from: http://www.goldcopd.org/. Accessed October 19, 2014.
16. Kamio K, Ishii T, Motegi T, et al. Decreased serum transforming growth factor-β1 concentration with aging is associated with the severity of emphysema in chronic obstructive pulmonary disease. Geriatr Gerontol Int. 2013;13(4):1069–1075.
17. Hardie JA, Buist AS, Vollmer WM, Ellingsen I, Bakke PS, Mørkve O. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J. 2002;20(5):1117–1122.
18. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165–1185.
19. Zervas E, Samitas K, Gaga M, et al. Inhaled corticosteroids in COPD: Pros and cons. Curr Drug Targets. 2013;14(2):192–224.
20. Budweiser S, Jörres RA, Pfeifer M. Treatment of respiratory failure in COPD. Int J Chron Obstruct Pulmon Dis. 2008;3(4):605–618.
21. deFilippi CR, de Lemos JA, Christenson RH, et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA. 2010;304(22):2494–2502.
22. Eggers KM, Al-Shakarchi J, Berglund L, et al. High-sensitive cardiac troponin T and its relations to cardiovascular risk factors, morbidity, and mortality in elderly men. Am Heart J. 2013;166(3):541–548.
23. Van Remoortel H, Hornikx M, Langer D, et al. Risk factors and comorbidities in the preclinical stages of chronic obstructive pulmonary disease. Am J Crit Care Med. 2014;189(1):30–38.
24. Lachin JM. Introduction to sample size determination and power analysis for clinical trials. Control Clin Trials. 1981;2(2):93–113.
25. Inami T, Seino Y, Otsuka T, et al. Links between sleep disordered breathing, coronary atherosclerotic burden, and cardiac biomarkers in patients with stable coronary artery disease. J Cardiol. 2012;60(3):180–186.
26. Randby A, Namtvedt SK, Einvik G, et al. Obstructive sleep apnea is associated with increased high-sensitivity cardiac troponin T levels. Chest. 2012;142(3):639–646.
27. Zamarrón C, García Paz V, Morete E, del Campo Matías F. Association of chronic obstructive pulmonary disease and obstructive sleep apnea consequences. Int J Chron Obstruct Pulmon Dis. 2008;3(4):671–682.
28. Global Initiative for Chronic Obstructive Lung Disease Executive Committee. 2004 update: Workshop Report, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Medical Communications Resources, Inc. Updated 2004. Available from: http://www.goldcopd.org/. Accessed October 19, 2014.
29. Japanese Respiratory Society. [The predicted values of spirometry and arterial blood gas analysis in Japanese]. J Jpn Respir Soc. 2001;39:1–17. Japanese.
30. Cheitlin MD, Armstrong WF, Aurigemma GP, et al. American College of Cardiology, American Heart Association, American Society of Echocardiography. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation. 2003;108(9):1146–1162.